News

Their own mini-boom of recent years has been largely fueled by one firm, Ozempic maker Novo Nordisk A/S, whose diabetes and ...
Steven Cheung slammed Daily Best exec Joanna Coles as a 'piece of s***' with a 'pea-sized brain' after she spoke about ...
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them.
Wellness influencer Janelle Rohner reveals she is 'microdosing' GLP-1 medication for weight loss and addresses criticism over ...
Cheung, one of Trump's closest allies, reffered to Coles as a "piece of sh*t" after she speculated the president might not be ...
We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential.
Highlights Semaglutide medications like Ozempic may cause facial changes. You can take steps to help minimize or prevent ...
Health and wellness influencer Janelle Rohner has received backlash after revealing in a YouTube video posted on April 23 ...
Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...
Runners, cyclists and other fitness enthusiasts say weight-loss drugs give them a performance edge, despite potential risks.
Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.
Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...